P. Auewarakul/L. Gissmann/A. Cid-Arregui: Targeted expression of E6
and E7 oncogenes of human papillomavirus type 16 in the epidermis of
transgenic mice elicits generalized hyperplasia involving autokrine
factors. Mol. Cell. Biol. 14 (1994), 8250-8258.

J. Bavinck a.o.: Relation between skin cancer, humoral responses to
human papillomaviruses, and HLA class II molecules in renal transplant
recipients. J. Immunol. 151 (1993), 1579-1586.

V. Bouvard/A. Storey/D. Pim/L. Banks: Characterization of hte human
papillomavirus E2 protein - evidence of trans-activation and
trans-repression in cervical keratinocytes.
EMBO Journal 13 (1994), 5451-5459.

S. Comerford a.o.: E6 and E7 expression from HPV 18 LCR - development
of genital hyperplasia and neoplasia in transgenic mice.
Oncogene 10 (1995), 587-597.

X. Dong/F. Stubenrauch/E. Beyer-Finkler/H. Pfister: Prevalence of
deletions of YY1-binding sites in episomal HPV 16 DNA from cervical
cancers. Int. J. Cancer 58 (1994), 803-808.

K. Haller/F. Stubenrauch/H. Pfister: Differentiation-dependent
transcription of the epidermodysplaisa verruciformis-associated human
papillomavirus type 5 in benign lesions. Virology 214 (1995), 245-255.

Harald zur Hausen: Human papillomaviruses in the pathogenesis of
anogenital cancer. Virology 184 (1991), 9-13.

M. May a.o.: The E6/E7 promotor of extrachromosomal HPV 16 DNA in
cervical cancers escapes from cellular repression by mutation of
target sequences for YY1. EMBO J. 13 (1994), 1460-1466.

9592 Susanne Modrow/Dietrich Falke: Molekulare Virologie. Spektrum 1997.

J. Paavonen: Pathophysioloigc aspects of human papillomavirus
infection. Curr. Op. Inf. Dis. 6 (1993), 21-26.

H. Pfister: Papillomviren, Krebs und Immunsuppression.
AIFO 7 (1992), 115-124.

F. Stubenrauch/I. Leigh/H. Pfister: E2 represses the late promotor of
human papillomavirus type 8 at high concentrations by interfering with
cellular factors. J. Virol. 70 (1996), 119-126.

K. Seedorf a.o.: Human papillomavirus type 16 DNA sequence.
Virology 145 (1985), 181-185.